title: Dietary soy and tea mitigate chronic inflammation and prostate cancer via NFκB pathway in the Noble rat model.
abstract: Chronic inflammation and nuclear factor-kappa B (NFκB) have been implicated in prostate cancer development; thus, dietary factors that inhibit NFκB may serve as effective chemo-preventative agents. Prostate cancer risk is significantly lower in Asian countries compared to the United States, which has prompted interest in the potential chemopreventative action of Asian dietary components such as soy and green tea. This study examined the effects of dietary soy and tea on NFκB activation and inflammation in vivo using a hormone-induced rat model for prostate cancer. Male Noble rats implanted with estradiol and testosterone were divided into 4 dietary groups: control, soy, tea, or soy+tea. NFκB activation and inflammatory cytokines were measured post implantation. The combination of soy and tea suppressed NFκB p50 binding activity and protein levels via induction of IκBα. Soy and tea also decreased prostate inflammatory infiltration, increased Bax/BcL2 ratio and decreased protein expression of tumor necrosis factor-alpha, interleukin (IL)-6 and IL-1β compared to control. Soy and tea attenuated prostate malignancy by decreasing prostate hyperplasia. These effects were not apparent in groups treated with soy or tea alone. The ongoing in vivo studies thus far suggest that combination of foods, such as soy and tea, may inhibit hormone-induced proinflammatory NFκB signals that contribute to prostate cancer development.
authors.affiliation: Department of Nutrition and Exercise Sciences, Oregon State University, Corvallis, OR 97331, USA.
authors.forename: Anna
authors.initials: A
authors.lastname: Hsu
authors.forename: Richard S
authors.initials: RS
authors.lastname: Bruno
authors.forename: Christiane V
authors.initials: CV
authors.lastname: Löhr
authors.forename: Alan W
authors.initials: AW
authors.lastname: Taylor
authors.forename: Rodrick H
authors.initials: RH
authors.lastname: Dashwood
authors.forename: Tammy M
authors.initials: TM
authors.lastname: Bray
authors.forename: Emily
authors.initials: E
authors.lastname: Ho
mesh_terms: D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology*; D000970:Antineoplastic Agents / Q000494:pharmacology*; D002392:Catechin / Q000032:analysis / Q000494:pharmacology; D002908:Chronic Disease; D004032:Diet; D004195:Disease Models, Animal; D004958:Estradiol / Q000097:blood; D020672:I-kappa B Proteins / Q000378:metabolism; D007249:Inflammation / Q000188:drug therapy; D053583:Interleukin-1beta / Q000378:metabolism; D015850:Interleukin-6 / Q000378:metabolism; D007529:Isoflavones / Q000097:blood; D008297:Male; D000072000:NF-KappaB Inhibitor alpha; D016328:NF-kappa B / Q000378:metabolism*; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000517:prevention & control; D051381:Rats; D015398:Signal Transduction; D045730:Soy Foods / Q000032:analysis; D013025:Glycine max / Q000737:chemistry*; D013662:Tea / Q000737:chemistry*; D013739:Testosterone / Q000097:blood; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism; D051028:bcl-2-Associated X Protein / Q000378:metabolism
chemical_list: D000893:Anti-Inflammatory Agents; D000970:Antineoplastic Agents; C494828:Bax protein, rat; D020672:I-kappa B Proteins; D053583:Interleukin-1beta; D015850:Interleukin-6; D007529:Isoflavones; D016328:NF-kappa B; C000606206:Nfkbia protein, rat; D013662:Tea; D014409:Tumor Necrosis Factor-alpha; D051028:bcl-2-Associated X Protein; D000072000:NF-KappaB Inhibitor alpha; D013739:Testosterone; C065753:isoflavanone; D004958:Estradiol; D002392:Catechin
references.citation: Eur J Cancer Prev. 2008 Nov;17(6):489-501
references.pmid: 18941371
references.citation: Cancer Res. 2001 Sep 15;61(18):6777-82
references.pmid: 11559550
references.citation: Am J Clin Nutr. 2000 Jun;71(6 Suppl):1705S-7S; discussion 1708S-9S
references.pmid: 10837323
references.citation: J Cell Biochem Suppl. 1997;27:52-8
references.pmid: 9591193
references.citation: Clin Cancer Res. 2004 Nov 15;10(22):7727-37
references.pmid: 15570007
references.citation: Oncogene. 2008 Oct 20;27(48):6252-75
references.pmid: 18931692
references.citation: Int J Cancer. 1997 Jan 27;70(3):255-8
references.pmid: 9033623
references.citation: Epidemiology. 1995 Jan;6(1):49-54
references.pmid: 7888445
references.citation: Food Chem Toxicol. 1995 Jan;33(1):27-30
references.pmid: 7821873
references.citation: J Cell Biochem. 2004 Jan 1;91(1):100-17
references.pmid: 14689584
references.citation: J Nutr. 2005 Jun;135(6):1400-6
references.pmid: 15930444
references.citation: Cell. 2004 Aug 6;118(3):285-96
references.pmid: 15294155
references.citation: Anticancer Res. 1984 Jul-Oct;4(4-5):255-6
references.pmid: 6486730
references.citation: J Nutr. 2007 Jan;137(1 Suppl):267S-269S
references.pmid: 17182838
references.citation: J Nutr. 2003 Feb;133(2):516-21
references.pmid: 12566493
references.citation: Carcinogenesis. 1996 Jul;17(7):1451-7
references.pmid: 8706248
references.citation: BMC Cancer. 2006 Apr 26;6:107
references.pmid: 16640785
references.citation: J Nutr. 2003 Jul;133(7 Suppl):2417S-2424S
references.pmid: 12840218
references.citation: Ann N Y Acad Sci. 2004 Dec;1028:247-57
references.pmid: 15650250
references.citation: Carcinogenesis. 1998 Jan;19(1):1-27
references.pmid: 9472688
references.citation: Cancer Lett. 1999 Sep 1;143(2):179-83
references.pmid: 10503900
references.citation: J Nutr. 2004 Nov;134(11):3177S-3178S
references.pmid: 15514295
references.citation: Nutr Rev. 2003 Apr;61(4):117-31
references.pmid: 12795445
references.citation: Anticancer Agents Med Chem. 2006 Sep;6(5):389-406
references.pmid: 17017850
references.citation: Carcinogenesis. 2005 Jul;26(7):1170-81
references.pmid: 15498784
references.citation: Cancer Prev Res (Phila). 2009 Jun;2(6):514-7
references.pmid: 19470792
references.citation: BMJ. 2006 Jun 3;332(7553):1302-8
references.pmid: 16740558
references.citation: Jpn J Cancer Res. 1998 Mar;89(3):254-61
references.pmid: 9600118
references.citation: Mol Carcinog. 2006 Jun;45(6):355-61
references.pmid: 16673382
references.citation: J Nutr. 1995 Mar;125(3 Suppl):790S-797S
references.pmid: 7533831
references.citation: Am J Pathol. 2007 Oct;171(4):1334-41
references.pmid: 17717140
references.citation: J Urol. 1999 Jan;161(1):152-5
references.pmid: 10037388
references.citation: Am J Clin Nutr. 1998 Dec;68(6 Suppl):1492S-1495S
references.pmid: 9848522
references.citation: World J Gastroenterol. 2007 Feb 28;13(8):1162-9
references.pmid: 17451194
references.citation: Cancer Causes Control. 1998 Mar;9(2):209-16
references.pmid: 9578298
references.citation: Carcinogenesis. 2002 Feb;23(2):329-33
references.pmid: 11872641
references.citation: Annu Rev Plant Biol. 2004;55:225-61
references.pmid: 15377220
references.citation: Nature. 2007 Apr 5;446(7136):690-4
references.pmid: 17377533
references.citation: Prostate. 2008 Sep 1;68(12):1296-306
references.pmid: 18500685
references.citation: Clin Cancer Res. 2009 Mar 15;15(6):1947-53
references.pmid: 19276266
references.citation: J Steroid Biochem Mol Biol. 2004 Nov;92(4):281-6
references.pmid: 15663991
references.citation: Cancer Res. 1977 Jun;37(6):1929-33
references.pmid: 858144
references.citation: Pharm Res. 2008 Sep;25(9):2135-42
references.pmid: 18317887
references.citation: Toxicol Appl Pharmacol. 1992 Feb;112(2):300-9
references.pmid: 1539166
references.citation: Prostate. 2002 Aug 1;52(3):183-200
references.pmid: 12111695
references.citation: Am J Clin Nutr. 2009 Jul;90(1):234-42
references.pmid: 19474141
references.citation: CA Cancer J Clin. 2008 Mar-Apr;58(2):71-96
references.pmid: 18287387
references.citation: Carcinogenesis. 1995 Jun;16(6):1311-7
references.pmid: 7788848
references.citation: Cancer Res. 2004 Dec 1;64(23):8715-22
references.pmid: 15574782
references.citation: Prostate. 2006 Feb 15;66(3):257-65
references.pmid: 16175586
references.citation: J Nutr. 2006 Jan;136(1):75-82
references.pmid: 16365062
references.citation: Acta Oncol. 1991;30(2):133-40
references.pmid: 2029395
references.citation: Environ Mol Mutagen. 1997;30(4):468-74
references.pmid: 9435888
references.citation: Carcinogenesis. 1995 Apr;16(4):951-4
references.pmid: 7728979
references.citation: Biochem Pharmacol. 2003 Sep 15;66(6):965-76
references.pmid: 12963483
references.citation: Prostate. 2003 Feb 15;54(3):169-80
references.pmid: 12518321
references.citation: Mutat Res. 1998 Jun 18;402(1-2):307-10
references.pmid: 9675322
references.citation: Carcinogenesis. 2008 Oct;29(10):2019-24
references.pmid: 18684728
references.citation: Nature. 2004 Sep 23;431(7007):461-6
references.pmid: 15329734
references.citation: J Nutr. 2006 Mar;136(3):704-8
references.pmid: 16484547
references.citation: Clin Cancer Res. 2002 Jul;8(7):2369-77
references.pmid: 12114442
references.citation: CA Cancer J Clin. 2007 Jan-Feb;57(1):43-66
references.pmid: 17237035
references.citation: Biol Pharm Bull. 2001 Aug;24(8):883-6
references.pmid: 11510478
references.citation: Carcinogenesis. 2004 Sep;25(9):1649-57
references.pmid: 15131010